Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Sensus Healthcare Q2 2024 GAAP EPS $0.10 Beats $0.02 Estimate, Sales $9.239M Beat $7.002M Estimate

Author: Benzinga Newsdesk | August 08, 2024 05:49pm
Sensus Healthcare (NASDAQ:SRTS) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.02 by 400 percent. This is a 600 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $9.239 million which beat the analyst consensus estimate of $7.002 million by 31.95 percent. This is a 104.09 percent increase over sales of $4.527 million the same period last year.

Posted In: SRTS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist